Previous Close | 0.9374 |
Open | 0.9500 |
Bid | 0.9876 x 600 |
Ask | 1.0200 x 1000 |
Day's Range | 0.9500 - 1.1400 |
52 Week Range | 0.5010 - 5.2870 |
Volume | |
Avg. Volume | 1,326,227 |
Market Cap | 51.467M |
Beta (5Y Monthly) | 1.66 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Eyenovia (EYEN) plunges 18% after sharing plans to consider strategic alternatives involving the sale of the company or assets, amid a severe cash crunch and poor performance of marketed drugs.
Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
Eyenovia, Inc. (NASDAQ:EYEN) Q4 2023 Earnings Call Transcript March 18, 2024 Eyenovia, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to Eyenovia’s Fourth Quarter and Full Year 2023 Earnings Call. At this time, all participants are […]